COMPOUNDS FOR TREATING DEMYELINATION CONDITIONS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100260716A1
SERIAL NO

12682852

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Therapeutic methods, therapeutic combinations and pharmaceutical compositions provided herein are useful for inhibiting demyelination, for delaying the clinical onset of a demylination condition, for inhibiting progression and/or reducing frequency of relapse of a demylination condition, and/or enhancing physical ability of a human subject having a demylination condition. Lacosamide is one of the active compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UCB PHARMA GMBHALFRED-NOBEL-STRASSE 10 MONHEIM 40789

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Rudd, David Raleigh, US 24 228
Stöhr, Thomas Monheim, DE 17 92

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation